Federal contract award

75N96021F00007

CONTRACT NO. HHSN273201600002I - CLINICAL RESEARCH SUPPORT SERVICES FOR NIEHS TASK ORDER NO. 75N96021F00007 - CLINICAL MONITORING ACTIVITIES BASE PERIOD - 07/01/2021-06/30/2022

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTE OF HEALTH NIEHS
NAICS541712
PSCAJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Parent award / vehicleHHSN273201600002I
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$1.4M
Current contract value$1.4M
Potential contract value / ceiling$1.4M
Start dateJul 1, 2021
Current end dateJun 30, 2026
Potential end dateJun 30, 2026
Latest award activityAug 7, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 7, 2026P00007$-512TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
Dec 16, 2025P00006$0TASK ORDER 7R - CLINICAL MONITORING ACTIVITIES
Jun 25, 2025P00005$282.7KTASK ORDER 7R - CLINICAL MONITORING ACTIVITIES
Jun 12, 2024P00004$276.3KTASK ORDER 7R - CLINICAL MONITORING ACTIVITIES
Jun 26, 2023P00003$270.1KTASK ORDER 7R - CLINICAL MONITORING ACTIVITIES
Jun 7, 2022P00002$264.1KTASK ORDER 7R - CLINICAL MONITORING ACTIVITIES
Aug 23, 2021P00001$83.2KTASK ORDER 7R - CLINICAL MONITORING ACTIVITIES
Jun 21, 20210$175.0KCONTRACT NO. HHSN273201600002I - CLINICAL RESEARCH SUPPORT SERVICES FOR NIEHS TASK ORDER NO. 75N96021F00007 - CLINICAL MONITORING ACTIVITIES BASE PERIOD - 07/01/2021-06/30/2022

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.